-+ 0.00%
-+ 0.00%
-+ 0.00%
Peptide (4587) 2Q operating loss narrowed (▲2.534 billion yen 1-6 months consolidated IFRS), 2026/12 forecast (4.6 billion yen)
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending